Epocrates Inc. Appoints Former Pfizer Inc. (PFE) Executive Peter Brandt to Board of Directors
2/3/2011 8:39:38 AM
SAN MATEO, Calif.--(BUSINESS WIRE)--Epocrates, Inc. (NASDAQ:EPOC), a leading provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry, today announced the effectiveness of the appointment of Peter C. Brandt to its board of directors. Brandt has extensive experience in leading financial, organizational and operational initiatives with top pharmaceutical companies. As a member of the Epocrates board, Brandt is expected to work closely with company leadership to guide the strategic direction of its interactive services for the healthcare industry. Brandt will also become a member of the board’s audit and compensation committees.